![]() Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. | ![]() Cellink CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products. | |
Founding Date | Founding Date 2014 | Founding Date 2016 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations London, GB HQ London, GB | Locations Göteborg, SE HQ Dardilly, FR Kyoto, JP Göteborg, SE Brighton, GB Blacksburg, US Boston, US |
Employees | Employees 647 | Employees 851% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) kr74.2m (FY, 2021) |
Cost of goods | Cost of goods $86.6m (FY, 2025) | Cost of goods kr40.2m (FY, 2021) |
Gross profit | Gross profit ($10.7m) (FY, 2025) | Gross profit kr34.1m (FY, 2021) |
Net income | Net income ($287.5m) (FY, 2025) | Net income (kr27.4m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 281.7m | Total funding raised $ 4.1m |

CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
View company